Ledger.Open graph →
SEC Form D · filed March 22, 2023

RS BioTherapeutics Inc

Offering
$10.0M
Sold
$100K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CUMBERLAND, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Dustin D. Freas · Cumberland, MDDirectorRobert M. Gelb · New York, NYDirectorMichael D. Guzman · Cumberland, MDExecH. D. Hart · Cumberland, MDExecCurtis D. Rhine · Cumberland, MDExecJustin D. Molignoni · Cumberland, MDExec · DirectorGlen Chesir · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗